CTMX Competitors & Alternatives
Compare CytomX Therapeutics Inc with similar stocks in the same industry
Biotechnology
CTMX
Main Stock$2.56
Tradestie Score
46
Market Cap
$552.46M
Revenue Growth
-0.9%
Analyst Upside
+378.5%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$14.74
|
$626.91M | - | 67 | Compare |
|
SVRA
Savara Inc.
|
$4.81
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$7.70
|
$541.60M | - | 54 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.90
|
$540.97M | - | 47 | Compare |
|
MPLT
MPLT
|
$9.82
|
$535.19M | - | 47 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.99
|
$529.35M | 10.9 | 47 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$77.97
|
$522.78M | - | 57 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.82
|
$512.39M | - | 65 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$47.15
|
$505.12M | 2.9 | 57 | Compare |
More CTMX Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry